Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Treon

Showing results (291-300 of 323) with videos related to

Pageof 33
Sort By:
Nature Medicine|July 5, 2024
Author Correction: The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cellsDi Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2021
Venetoclax in Previously Treated Waldenström MacroglobulinemiaJorge J Castillo, John N Allan, Tanya Siddiqi, et al.
American Journal of Hematology|March 10, 2025
Depth of Response From Fixed-Duration Treatment Is Associated With Superior Survival in Waldenstrom MacroglobulinemiaJonas Paludo, Jithma P Abeykoon, Nirosha D Perera, et al.
Nature Medicine|May 26, 2015
The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cellsDi Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
Nature Medicine|January 25, 2024
Author Correction: The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cellsDi Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
Blood|June 13, 2012
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myelomaYu-Tzu Tai, Betty Y Chang, Sun-Young Kong, et al.
Blood|August 21, 2008
Thalidomide and rituximab in Waldenstrom macroglobulinemiaSteven P Treon, Jacob D Soumerai, Andrew R Branagan, et al.
Blood Cancer Journal|February 2, 2020
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomasManit Munshi, Xia Liu, Jiaji G Chen, et al.
Blood|July 17, 2014
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensusMeletios A Dimopoulos, Efstathios Kastritis, Roger G Owen, et al.
British Journal of Haematology|December 15, 2015
Clonal architecture of CXCR4 WHIM-like mutations in Waldenström MacroglobulinaemiaLian Xu, Zachary R Hunter, Nicholas Tsakmaklis, et al.
Pageof 33

Showing results (291-300 of 323) with videos related to

Sort By:
Pageof 33
Nature Medicine|July 5, 2024
Author Correction: The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cellsDi Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2021
Venetoclax in Previously Treated Waldenström MacroglobulinemiaJorge J Castillo, John N Allan, Tanya Siddiqi, et al.
American Journal of Hematology|March 10, 2025
Depth of Response From Fixed-Duration Treatment Is Associated With Superior Survival in Waldenstrom MacroglobulinemiaJonas Paludo, Jithma P Abeykoon, Nirosha D Perera, et al.
Nature Medicine|May 26, 2015
The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cellsDi Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
Nature Medicine|January 25, 2024
Author Correction: The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cellsDi Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
Blood|June 13, 2012
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myelomaYu-Tzu Tai, Betty Y Chang, Sun-Young Kong, et al.
Blood|August 21, 2008
Thalidomide and rituximab in Waldenstrom macroglobulinemiaSteven P Treon, Jacob D Soumerai, Andrew R Branagan, et al.
Blood Cancer Journal|February 2, 2020
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomasManit Munshi, Xia Liu, Jiaji G Chen, et al.
Blood|July 17, 2014
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensusMeletios A Dimopoulos, Efstathios Kastritis, Roger G Owen, et al.
British Journal of Haematology|December 15, 2015
Clonal architecture of CXCR4 WHIM-like mutations in Waldenström MacroglobulinaemiaLian Xu, Zachary R Hunter, Nicholas Tsakmaklis, et al.
Pageof 33